Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
“I am profoundly deaf, but I sleep great.” -Marlee Matlin
Disclaimer: Any material provided is intended as general information only, and should not be considered or relied upon as a formal investment recommendation.
We have investment positions in some of the securities we write about, and our positions are subject to change at any time. Nothing here is to be deemed a solicitation for investment nor investment advice. Please read our full legal disclaimer available on our blog. http://lazarusip.blogspot.com/
I am a long time buy-and-hold investor from Cleveland, Ohio, with approximately 6 years investing experience.
I primarily target Value stocks, but on occasion am open to "growth at a reasonable price."
Ideally I prefer to invest in Mid-Cap stocks over large-cap or small-cap.
I believe the two best sectors to invest in during the next two decades will be Health Care for growth and Financials for value.
I tend to ignore the opinions of hedge-fund managers or so-called "experts"....rather, my investment philosophy values the opinion of simple minds that come from humble backgrounds.
I am always on a look-out for secular trends; I look for companies that benefit from aging baby boomers, rising interest rates, organic eating, and increased adoption of electronic payment systems.
I tend to pay more attention to a company's qualitative aspects rather than quantitative.
My top 10 stock holdings:
1. PayPal (PYPL)
2. Opko Health (OPK)
3. Berkshire Hathaway (BRK.B)
4. Markel Corp (MKL)
5. Canadian National Railway (CNI)
6. U.S. Bancorp (USB)
7. Visa (V)
8. Wells Fargo (WFC)
9. CVS Health Corp (CVS)
10. WhiteWave Foods (WWAV)
I'm an independent equity researcher, writer and investor based in Amsterdam. My primary focus is on the micro-cap segment of the market. I also work for pension funds as a member of the Board and Investment Committee. Lastly, I enjoy soccer, sports in general and brewing the best coffee one can make at home.
I am a retired wall street attorney. I started out specializing exclusively in securities law. As I developed my practice, it morphed into a corporate finance practice specializing in mergers and acquisitions, with the securities law aspects being secondary.
I'm not much for diversification. I tend to put a substantial amount in a few baskets and then watch those baskets very, very carefully.
Spent my entire 28 year career on Wall Street with over a decade at Bear Stearns. No "Wall Street Titan" in real life but WST is an alias that I've used for years on Yahoo so I use it when I write on SA. I have gained a significant amount of knowledge regarding the stem cell sector over the years and have recently launched a premium service covering this exciting area.
I am a global macro investor, financial journalist and weekend entrepreneur. As a global macro investor, I like to make bets on countries/regions using ETFs/options and usually have a six month to one year timeframe. As a financial journalist, I write for About.com's International Investing section, Investopedia.com, and a number of other places. And as a weekend entrepreneur, I enjoy developing website and mobile apps to learn new languages/technologies.
An entrepreneurial generalist who has served principally as a business leader and consultant in the information technology, communications, and business services arenas. Now retired, a stock picker and writer who enjoys writing about the semiconductor memory industry, among other things. When I'm not doing that I'm backpacking, cycling, and playing with my grandchildren.
HFI Research is a premium service dedicated to long-term oriented investors with a focus on non-consensus idea generation. We provide real-time trade alerts, idea generation, and portfolio recommendations. In addition, we write a weekly HFI portfolio update that highlights the positions in the portfolio. Other benefits to being a premium subscriber includes immediate access to the HFI Research team and a subscriber only chat platform. Our TipRank profile: https://www.tipranks.com/bloggers/hfi
We try to provide unbiased, balanced and helpful insight into long-term prospects of the businesses we follow. We mainly base our analysis on the fundamentals and assess the long-term growth potential of the companies. In addition, we also analyze the dividend stability of different companies, and try to assess the future cash flows in order to gauge dividend growth potential.
You can also follow us on twitter here:https://twitter.com/IAEResearch
Civil engineer using nurtured logical predictive ability to increase my retirement accounts and thereby recover somewhat from the one two punch of a divorce (in 2007 I borrowed to settle and keep real estate) and real estate downturn (2008 my real estate went underwater).
Started investing in stocks in mid-2013 with $100k in a Roth IRA. Dropped to $69k, up to $500k, down to $105k, up to $670k, down to $315k, up to $850k. Goal is $4m by end of 2015. I am more than half way there having achieved an 8.5 bagger (end of 2015), I only need another 5 bagger to exceed my goal. TAX FREE.
"A man who follows an independent and contrary path has no guarantee of making money… but a man who follows the great mass of conventional wisdom is practically guaranteed that he will not."
Riches are made through focus and concentration on a few stocks. Riches are kept through diversification . . .
Current investments: RiteAid and Intel LEAPS
LEAPS for Fun and Profit: service only available to family and close friends :-)
Don't try what I am doing without your own extensive research.
Post-graduate student in chemical + bioengineering, get my kicks by learning about things that interest me! Looking to use my expertise and knowledge to better communicate biotech trade ideas to the average investor.
I hold a PhD in the field of epidemiology a masters degree in public health. My undergraduate training is in policy, economics and the sciences. I have utilized my training in employment with government, academia, private industry and to further analyze the fundamentals and technicals of all manner of companies in different sectors. Specifically, I like to trade growth companies, REITS, biotechnology/ pharmaceuticals, precious metals, blue chips and small-cap companies.
Each market day I get up at 530 am and begin working/analyzing data before my day job. I focus much on current events, earnings, and developments. I also work after market hours to cover after hours developments or interesting action during the day. I aim to conduct 2 analysis per business day, which helps me stay focused on my own finances.
I have been investing for about 10 years. I also enjoy trading short expiration options, and investing in stocks with 3-20 year horizons. I enjoy writing with Seeking Alpha to share my opinion and analyses. I am a large believer in the crowd source model championed by Seeking Alpha and believe every ounce of analysis and opinion should be considered when you invest your personal finances.
ZVI BAR LLC is a legal and financial trust consultancy based on Wall Street, and a leading authority on trust administration and estate planning. ZVI BAR LLC was founded by Zvi Bar-Kochba, an attorney and consultant on trust administration that provides advisory services for trusts and beneficiaries. ZVI BAR LLC provides consulting expert services regarding prudent investing, securities regulations and evaluations of potential fiduciary liability.
Publications here are written by agents, representatives and individuals associated with or contracted by ZVI BAR LLC. No articles or discussions here shall constitute a legal, fiduciary or advisory role, but solely act as informative press and/or a starting point from which further discussion may follow. Comments are welcome, as are questions.
John Hodge is an active trader who follows the technology/biotech sector specifically. I have been successfully trading stocks for the last 16 years and still thank those that pointed me in the direction of Qualcomm and Amgen many years ago. I believe research and timing is the key to long term goal attainment in the market.
I have been trading part time for the past 10 years, focusing on swing trades and identifying how different stocks will "inhale and exhale" through the market. My primary targets are in the $2-$10 range, averaging over 2 million shares traded daily, and looking for an upswing. My goal is to average 10% per month, but will hold on for the long run with stocks that I believe in.
Ashraf Eassa is a technology specialist with The Motley Fool. He writes mostly about technology stocks, but is especially interested in anything related to chips -- the semiconductor kind, that is.
Old school investment analysis by 30 year stock market veteran Stan Barton.
The past editor of STOCK ACTION advisory letter and past coordinator of the MENSA investment group is now helping successful people develop and preserve their legacy at Barton Legacy Advisor, LLC.
For a free consultation contact him at www.bartonla.com
Gotham City Capital is a private, biotech research company. Our main objective is to provide investors with low-risk, high reward biotech investments and trades. We place the utmost emphasis on small cap bios that specialize in the most promising therapies out there. In our articles, we will aim to be very specific in our strategy, whether it be a catalyst run-up trade, swing trade or long-term investment. We strive to offer consistent opportunities for investors to create high returns on our biotech picks.
With approximately six year of studies, we feel that we have an excellent balance of expertise between trading, company financing, company management and most specifically, trial data. A solid track record of successfully finding the best trades and companies has driven us to start this company. We believe in making decent size bets on the best companies.
For real time market commentary, make sure to follow Gotham City Capital on Twitter.
I am an independent investor helping retail investors beat Wall Street to undiscovered high technology and biotechnology growth stocks.
University of Michigan (1987) - Bachelors Degree in Business, Professional Accounting, Finance and Managerial Economics
Michigan State University School of Law (1994) - Area of Practice Medical-Legal Cases
Bookmark QTR's new blog, where exclusive (and always FREE) content will be available: http://www.quoththeravenresearch.com
Visit QTR and check out trading ideas, commentary, and me arguing with idiots on Twitter: http://www.twitter.com/quoththeravensa
QTR's ARTICLES ARE BOUND BY SA'S CONTRIBUTOR POLICY IN ADDITION TO THIS ENTIRE LENGTHY, YET EXTREMELY PERTINENT ADD ON DISCLOSURE, WHICH SERVES AS BOTH A STANDALONE DISCLOSURE AND AN AMENDMENT TO ANY AND ALL DISCLOSURES ALREADY PRESIDING OVER SEEKING ALPHA:
Quoth the Raven's ("QTR") articles are the sole product of QTR and his personal, individual opinions. These articles are not associated with, in any way, the opinions, strategies, or works of QTR's employer, associates, or entities in any way otherwise related to QTR.
(i.e. This are solely my personal thoughts and opinions)
You agree that by reading Quoth the Raven's articles, you are acting at your OWN RISK. In NO EVENT should QTR be liable for any direct or indirect trading losses caused by any information contained in QTR's articles, StockTalks, or other internet-based dissemination methods. Information in QTR's articles are not an offer to sell or a solicitation of an offer to buy any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction. QTR is not suggesting the transacting of any financial instruments and QTR suggests consulting your personal financial adviser with regards to any such transactions.
QTR makes no representations, and specifically disclaims all warranties, express, implied, or statutory, regarding the accuracy, timeliness, or completeness of any material contained in this site. Again, you should seek the advice of your personal financial adviser or a security professional regarding your stock transactions.
QTR does not, in any way, guarantee that he is providing all of the information that may be available on any topic written. QTR recommends, again, that you do your own due diligence and consult a registered financial adviser before buying or selling any security.
QTR most always holds a position in any of the securities profiled in his pieces and he constructs his SA disclosures in accordance with SA's Contributor Policy, to the best of his knowledge in order to maintain transparency and also to uphold and respect pertinent securities laws. QTR may or may not report when a position is initiated or covered. Each investor must make that decision based on his/her judgment of the market.
I am not a stockbroker or financial adviser. I am a casual investor making casual observations for the purpose of discussion and open communication and analysis of companies and stocks. All articles are my opinion only and are not suggestions to buy or sell any equity, bond, option or other financial instrument. QTR may have long or short positions in any tickers mentioned at any time and reserves the right to open, close, or modify positions at all time without notice. My conclusions are the result of my personal due diligence and have been wrong in the past. There are tons of unqualified people out there offering up financial advice and its your responsibility to sort through the BS. You don't hit the button to fill my orders and I don't hit yours, so no whining or praising over stocks covered by me.
Follow QTR on Twitter: https://twitter.com/QuoththeRavenSA
View QTR's Stock Picking Performance for every article at TipRanks:
Semiconductor Veteran of over 20 years working at Intel and several prominent startups like Cyrix and Transmeta. I was a co-founder in an FPGA startup for nearly 5 years and now work with a leading edge non-volatile memory startup building Resistive RAM memories, which will eventually take the place of Flash as a lower power, higher performance and more economical solution.
I write occasionally on the mobile markets and the semiconductors that power them. Transmeta was the company that first highlighted the need for all day computing in the PC market. I was proud to be a part of the launch of the first truly low power x86 processor, which Intel then had to address.
I am a highly trained professional equity analyst. My specialty is finding companies with excellent ratios of risk to reward. Before going independent, I was the head analyst at a boutique Israeli hedge fund. Today I am a consultant to several multibillion-dollar firms. I have covered many sectors, including technology, solar and semiconductors. I have learned to connect the dots and discern how forces in these various industries will affect individual companies. I am a big believer in analyzing investments from the top down. This means identifying themes and trends that can reveal where industries and individual companies will be in the future. There are no magic formulas for this process, just a lot of hard work. After I've found a company, analyzed it and concluded its value, then it is just like a poker game with endless cards. All we have to do is sit and wait for the next card to reveal itself and adjust our thesis accordingly. Once we find the true value of a company, we must ignore day-to-day market chaos. If we have done our research properly, we do not need to worry if the Dow goes up or down a particular day, week or month. Peter Lynch, Ben Graham and Phillip Fisher are my biggest influences. I encourage anyone who wishes to learn more about the market to read any of their books.
I am a former investment advisor and owner of several businesses, and consequently everything related to business - including investing, macro-economics, and emerging products and services come under my research and interests radar.
The most interesting and important to me are the entertainment industry, commodities, BRICs, and the impact of loose money policies on businesses and investors.
These days I invest only for myself, while continuing to write on a variety of financial and economic topics.